1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. AJANTA PHARMA LTD.

Ajanta Pharma Ltd. NSE: AJANTPHARM | BSE: 532331

Ajanta Pharma Ltd. Live Share Price Today, Share Analysis and Chart

Falling Comet
Download real time

2565.40 95.25 (3.86%)

26.39% Fall from 52W High

90,546 NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Expensive Valuation
23.3 / 100
Momentum Score
Technically Bearish
28.8 / 100
Falling Comet These stocks are with good financial quality. But, their bad valuation and technical aspects make the investor think before investing. View Similar Embed DVM
Analyst Price Target
3,026
1Yr Price target upside is 18%
11 analysts

12

S

11

W

2

O

1

T

SWOT Analysis

Ajanta Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

03 Feb, 2025 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
30 Jan, 2025 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
30 Oct, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
28 Oct, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
02 Aug, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
30 Jul, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
08 May, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
02 May, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
05 Feb, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
31 Jan, 2024 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
03 Nov, 2023 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Earnings …
pdf link
31 Oct, 2023 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Analyst /…
pdf link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
29 Aug, 2024 CARE RATINGS
Ajanta Pharma Limited
pdf
12 Sep, 2023 CARE RATINGS
Ajanta Pharma Limited
pdf
12 Sep, 2022 CARE RATINGS
Ajanta Pharma Limited
pdf
31 Aug, 2021 CARE RATINGS
Ajanta Pharma Limited
pdf
05 Oct, 2020 CARE RATINGS
Ajanta Pharma Limited
The reaffirmation of rating to the bank facilities of Ajanta Pharma Limited (APL) continues to derive strength from experienced promoters …
pdf
25 Sep, 2019 CARE RATINGS
Ajanta Pharma Limited
pdf
05 Feb, 2020 BSE INDIA
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Investor P…
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
05 Nov, 2019 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
pdf link
31 Jul, 2019 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
pdf link
30 Apr, 2019 BSE INDIA
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Investor P…
Ajanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Investor P…
pdf link
30 Jan, 2019 BSE INDIA
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
AJANTA PHARMA LTD. - 532331 - Announcement under Regulation 30 (LODR)-Investor …
pdf link
31 Oct, 2018 BSE INDIA
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
pdf link
31 Jul, 2018 BSE INDIA
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
pdf link
02 May, 2018 BSE INDIA
Announcement under Regulation 30 (LODR)-Investor Presentation
Announcement under Regulation 30 (LODR)-Investor Presentation
pdf link
25 Jan, 2018 BSE INDIA
Investor Presentation
Investor Presentation
pdf link
31 Oct, 2017 BSE INDIA
Investor Presentation
Investor Presentation
pdf link
09 Aug, 2017 BSE INDIA
Investor Presentation
Investor Presentation
pdf link
24 Jan, 2017 BSE INDIA
Investor Presentation Q3 FY 2017
Investor Presentation Q3 FY 2017
pdf link

Ajanta Pharma Ltd. FAQ

How is Ajanta Pharma Ltd. today?
Ajanta Pharma Ltd. today is trading in the green, and is up by 3.86% at 2565.40.
Ajanta Pharma Ltd. is currently trading up 3.86% on an intraday basis. In the past week the stock rose 3.23%. stock has been down -9.48% in the past quarter and rose 21.28% in the past year. You can view this in the overview section.